NOGAMI Kyoko

写真a

Affiliation

Faculty of Medicine College Hospital Dermatology

Title

Assistant Professor

External Link

Related SDGs


 

Papers 【 display / non-display

  • Maximum Standard Uptake Value of Pre-Therapeutic (18)F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement. Reviewed

    Nogami K, Nishikawa Y, Mochida K, Terada T, Azuma M, Nakai M, Amano M

    The Journal of dermatology   52 ( 10 )   1519 - 1526   2025.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/1346-8138.17867

    PubMed

  • Maximum Standard Uptake Value of Pre-Therapeutic 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement. Reviewed

    野上 京子, 西川 陽太郎, 持田 耕介, 寺田 珠沙, 東 美菜子, 中井 陸運, 天野 正宏

    The Journal of Dermatology   2025.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:John Wiley & Sons  

    The prognostic utility of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in adult T-cell leukemia/lymphoma (ATLL) remains unclear, particularly in patients with indolent subtypes and cutaneous involvement. This study aimed to evaluate the usefulness of FDG-PET in predicting clinical outcomes in patients with indolent ATLL presenting with skin lesions. We retrospectively reviewed indolent ATLL with cutaneous involvement who underwent 18F-fluorodeoxyglucose positron emission tomography at our institute for initial disease staging between April 2007 and March 2022. The data obtained were compared with the findings of cutaneous involvement in ATLL. The effect of maximum standardized uptake value on progression-free survival was analyzed using the Kaplan-Meier method. Patients were divided into groups based on whether their maximum standardized uptake value was above or below the overall mean maximum standardized uptake value (2.18), and progression-free survival was compared between the groups. Forty-three patients with indolent ATLL were included. We divided the cutaneous involvement of ATLL into six subtypes according to a previously reported classification of eruption types: patch, plaque, multipapular, nodulotumoral, erythrodermic, and purpuric. A total of 18 of 43 patients (41.9%) had 18F-fluorodeoxyglucose-positive cutaneous lesions. However, 25 patients showed no 18F-fluorodeoxyglucose uptake in cutaneous lesions. There was a significant difference in the mean maximum standardized uptake value between the nodulotumoral and multipapular (p = 0.036), nodulotumoral and patch (p = 0.036). There was a statistically significant difference in progression-free survival between the maximum standardized uptake value ≥ 2.18 and < 2.18 groups (p = 0.020). These findings indicate that the maximum standardized uptake value in cutaneous lesions could determine the prognostic association of ATLL with cutaneous lesions. Careful follow-up is required for patients with a higher maximum standardized uptake value fo

    CiNii Research

  • 当科におけるHTLV-1キャリアの皮膚症状の検討

    野上 京子, 成田 幸代, 西川 陽太郎, 持田 耕介, 前久保 理恵, 瀬戸山 充, 天野 正宏

    Skin Cancer   39 ( 3 )   230 - 236   2024

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:日本皮膚悪性腫瘍学会  

    DOI: 10.5227/skincancer.39.230

    CiNii Research

  • 特集 バイオ治療~新しい展開 臨床例 尋常性乾癬と誤診し,生物学的製剤投与により増悪を認めた頭部・体部白癬 Reviewed

    福良 拓也, 西川 陽太郎, 野上 京子, 持田 耕介

    皮膚病診療   47 ( 10 )   892 - 896   2025.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:協和企画  

    DOI: 10.24733/pd.0000004276

    CiNii Research

  • 特集 アレルギー 5%マルトース加乳酸リンゲル液によるⅠ型アレルギーの1例 Reviewed

    田中 愛実, 野上 京子, 下西 広大, 天野 正宏

    皮膚科の臨床   67 ( 11 )   1399 - 1401   2025.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:金原出版  

    DOI: 10.18888/hi.0000005427

    CiNii Research

display all >>

Presentations 【 display / non-display

  • 当科におけるHTLV-1キャリアの皮膚症状の検討 Invited

    野上京子

    第10回HTLV-1学会学術集会  2024.11.9 

     More details

    Event date: 2024.11.8 - 2024.11.10

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

  • 当科における HTLV-1 キャリアの皮膚症状の検討 Invited

    野上京子

    第40回日本皮膚悪性腫瘍学会学術大会  2024.5.11 

     More details

    Event date: 2024.5.10 - 2024.5.11

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

  • 当科における抗 HTLV-1 抗体陽性乾癬患者と生物学的製剤使用についての検討

    野上京子

    第38回日本乾癬学会  2023.8.25 

     More details

    Event date: 2023.8.25 - 2023.8.26

    Language:Japanese   Presentation type:Oral presentation (general)  

  • 薬疹との鑑別を要したATLLの1例

    野上京子

    第37回日本皮膚科学会島根地方会  2022.8.7 

     More details

    Event date: 2022.8.6 - 2022.8.7

    Language:Japanese   Presentation type:Oral presentation (general)  

  • 皮膚Rosai-Dorfmanの一例

    中村俊央、野上京子、黒川基樹、天野正宏

    日本皮膚科学会第165回宮崎地方会  2024.12.15 

     More details

    Event date: 2024.12.14 - 2024.12.15

    Language:Japanese   Presentation type:Oral presentation (general)  

display all >>